Recently, our team attended the 2018 Inland Empire Stem Cell Consortium hosted by Western University of Health Sciences in Pomona. The IESCC is comprised of stem cell researchers located throughout the Inland Empire from four universities, including University of...
VetCell Therapeutics and the College of Veterinary Medicine at Western University of Health Sciences have been diligently working together on a clinical trial for canine atopic dermatitis (AD) throughout the year. The major goal for this study is to determine if stem...
This week marks an exciting point in our collaborative clinical study with Western University of Health Sciences on the treatment of canine Atopic Dermatitis with adipose MSCs. The process of the study has been ongoing for the past couple of months. During that...
Recently, the team at VetCell Therapeutics had the honor and privilege to meet with Democratic Congressman J. Luis (Lou) Correa (District 46). The focus of the meeting was to discuss the functionality and advancement of the biotech industry within Correa’s district....
Canine atopic dermatitis (AD) is a pruritic (unpleasant sensation that provokes the desire to scratch) skin disease that holds a complex pathogenesis. It results from a combination of immune system dysfunction, compromised skin barrier, and genetic predisposition to...
The main objective for a successful cell therapy treatment is to show a significant improvement as compared to the standard treatment regimen. This is actually a key decision point the FDA uses in consideration of approving a therapy. A given cell therapy from a...
